February 22, 2024
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Amgen boasts Horizon sales, investments in obesity market

IN THIS ARTICLE

Amgen's new research and development facility in San Francisco. (courtesy photo) It took nearly a year, but the impact of Amgen’s historic purchase of Horizon Therapeutics was finally felt on Feb. 6 when the company disclosed its earnings for the fourth quarter and full year 2023. Amgen, one of the largest biotechnology companies in the…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.